0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Anthrax Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-30F13951
Home | Market Reports | Health| Pharmacy
Global Anthrax Treatment Market Research Report 2023
BUY CHAPTERS

Anthrax Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-30F13951
Report
October 2024
Pages:159
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anthrax Treatment - Market Size

The global market for Anthrax Treatment was estimated to be worth US$ 558.7 million in 2023 and is forecast to a readjusted size of US$ 924 million by 2030 with a CAGR of 7.4% during the forecast period 2024-2030

Anthrax Treatment - Market

Anthrax Treatment - Market

Anthrax is a serious infectious disease caused by gram-positive, rod-shaped bacteria known as Bacillus anthracis. It occurs naturally in soil and commonly affects domestic and wild animals around the world. People can get sick with anthrax if they come in contact with infected animals or contaminated animal products.
North American market for Anthrax Treatment was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anthrax Treatment was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Anthrax Treatment was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Anthrax Treatment include Alembic Pharmaceuticals, Integrated Bio Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Zydus Group, Bayer AG, Pfizer Inc., EMERGENT, Sanofi and Elusys Therapeutics, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anthrax Treatment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anthrax Treatment by region & country, by Type, and by Application.
The Anthrax Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anthrax Treatment.
Market Segmentation

Scope of Anthrax Treatment - Market Report

Report Metric Details
Report Name Anthrax Treatment - Market
Forecasted market size in 2030 US$ 924 million
CAGR 7.4%
Forecasted years 2024 - 2030
Segment by Type:
  • Fluoroquinolone
  • Tetracycline
  • Others
Segment by Application
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alembic Pharmaceuticals, Integrated Bio Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Zydus Group, Bayer AG, Pfizer Inc., EMERGENT, Sanofi, Elusys Therapeutics, Porton Biopharma, Lupin, Soligenix, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., ARISTO Pharmaceuticals Private Limited, INDOCO REMEDIES LTD., Paratek Pharmaceuticals, Inc., DEINOVE, BlueWillow Biologics., GC Biopharma, corp., Altimmune
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Anthrax Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Anthrax Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Anthrax Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Anthrax Treatment - Market size in 2030?

Ans: The Anthrax Treatment - Market size in 2030 will be US$ 924 million.

Who are the main players in the Anthrax Treatment - Market report?

Ans: The main players in the Anthrax Treatment - Market are Alembic Pharmaceuticals, Integrated Bio Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Zydus Group, Bayer AG, Pfizer Inc., EMERGENT, Sanofi, Elusys Therapeutics, Porton Biopharma, Lupin, Soligenix, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., ARISTO Pharmaceuticals Private Limited, INDOCO REMEDIES LTD., Paratek Pharmaceuticals, Inc., DEINOVE, BlueWillow Biologics., GC Biopharma, corp., Altimmune

What are the Application segmentation covered in the Anthrax Treatment - Market report?

Ans: The Applications covered in the Anthrax Treatment - Market report are Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Anthrax Treatment - Market report?

Ans: The Types covered in the Anthrax Treatment - Market report are Fluoroquinolone, Tetracycline, Others

1 Market Overview
1.1 Anthrax Treatment Product Introduction
1.2 Global Anthrax Treatment Market Size Forecast
1.2.1 Global Anthrax Treatment Sales Value (2019-2030)
1.2.2 Global Anthrax Treatment Sales Volume (2019-2030)
1.2.3 Global Anthrax Treatment Sales Price (2019-2030)
1.3 Anthrax Treatment Market Trends & Drivers
1.3.1 Anthrax Treatment Industry Trends
1.3.2 Anthrax Treatment Market Drivers & Opportunity
1.3.3 Anthrax Treatment Market Challenges
1.3.4 Anthrax Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Anthrax Treatment Players Revenue Ranking (2023)
2.2 Global Anthrax Treatment Revenue by Company (2019-2024)
2.3 Global Anthrax Treatment Players Sales Volume Ranking (2023)
2.4 Global Anthrax Treatment Sales Volume by Company Players (2019-2024)
2.5 Global Anthrax Treatment Average Price by Company (2019-2024)
2.6 Key Manufacturers Anthrax Treatment Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Anthrax Treatment Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Anthrax Treatment
2.9 Anthrax Treatment Market Competitive Analysis
2.9.1 Anthrax Treatment Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Anthrax Treatment Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anthrax Treatment as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Fluoroquinolone
3.1.2 Tetracycline
3.1.3 Others
3.2 Global Anthrax Treatment Sales Value by Type
3.2.1 Global Anthrax Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Anthrax Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Anthrax Treatment Sales Value, by Type (%) (2019-2030)
3.3 Global Anthrax Treatment Sales Volume by Type
3.3.1 Global Anthrax Treatment Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Anthrax Treatment Sales Volume, by Type (2019-2030)
3.3.3 Global Anthrax Treatment Sales Volume, by Type (%) (2019-2030)
3.4 Global Anthrax Treatment Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Anthrax Treatment Sales Value by Application
4.2.1 Global Anthrax Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Anthrax Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Anthrax Treatment Sales Value, by Application (%) (2019-2030)
4.3 Global Anthrax Treatment Sales Volume by Application
4.3.1 Global Anthrax Treatment Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Anthrax Treatment Sales Volume, by Application (2019-2030)
4.3.3 Global Anthrax Treatment Sales Volume, by Application (%) (2019-2030)
4.4 Global Anthrax Treatment Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Anthrax Treatment Sales Value by Region
5.1.1 Global Anthrax Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Anthrax Treatment Sales Value by Region (2019-2024)
5.1.3 Global Anthrax Treatment Sales Value by Region (2025-2030)
5.1.4 Global Anthrax Treatment Sales Value by Region (%), (2019-2030)
5.2 Global Anthrax Treatment Sales Volume by Region
5.2.1 Global Anthrax Treatment Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Anthrax Treatment Sales Volume by Region (2019-2024)
5.2.3 Global Anthrax Treatment Sales Volume by Region (2025-2030)
5.2.4 Global Anthrax Treatment Sales Volume by Region (%), (2019-2030)
5.3 Global Anthrax Treatment Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Anthrax Treatment Sales Value, 2019-2030
5.4.2 North America Anthrax Treatment Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Anthrax Treatment Sales Value, 2019-2030
5.5.2 Europe Anthrax Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Anthrax Treatment Sales Value, 2019-2030
5.6.2 Asia Pacific Anthrax Treatment Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Anthrax Treatment Sales Value, 2019-2030
5.7.2 South America Anthrax Treatment Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Anthrax Treatment Sales Value, 2019-2030
5.8.2 Middle East & Africa Anthrax Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Anthrax Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Anthrax Treatment Sales Value
6.2.1 Key Countries/Regions Anthrax Treatment Sales Value, 2019-2030
6.2.2 Key Countries/Regions Anthrax Treatment Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Anthrax Treatment Sales Value, 2019-2030
6.3.2 United States Anthrax Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Anthrax Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Anthrax Treatment Sales Value, 2019-2030
6.4.2 Europe Anthrax Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Anthrax Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Anthrax Treatment Sales Value, 2019-2030
6.5.2 China Anthrax Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Anthrax Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Anthrax Treatment Sales Value, 2019-2030
6.6.2 Japan Anthrax Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Anthrax Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Anthrax Treatment Sales Value, 2019-2030
6.7.2 South Korea Anthrax Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Anthrax Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Anthrax Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Anthrax Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Anthrax Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Anthrax Treatment Sales Value, 2019-2030
6.9.2 India Anthrax Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Anthrax Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Alembic Pharmaceuticals
7.1.1 Alembic Pharmaceuticals Company Information
7.1.2 Alembic Pharmaceuticals Introduction and Business Overview
7.1.3 Alembic Pharmaceuticals Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Alembic Pharmaceuticals Anthrax Treatment Product Offerings
7.1.5 Alembic Pharmaceuticals Recent Development
7.2 Integrated Bio Therapeutics Inc.
7.2.1 Integrated Bio Therapeutics Inc. Company Information
7.2.2 Integrated Bio Therapeutics Inc. Introduction and Business Overview
7.2.3 Integrated Bio Therapeutics Inc. Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Integrated Bio Therapeutics Inc. Anthrax Treatment Product Offerings
7.2.5 Integrated Bio Therapeutics Inc. Recent Development
7.3 Sun Pharmaceutical Industries Ltd.
7.3.1 Sun Pharmaceutical Industries Ltd. Company Information
7.3.2 Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
7.3.3 Sun Pharmaceutical Industries Ltd. Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Sun Pharmaceutical Industries Ltd. Anthrax Treatment Product Offerings
7.3.5 Sun Pharmaceutical Industries Ltd. Recent Development
7.4 Zydus Group
7.4.1 Zydus Group Company Information
7.4.2 Zydus Group Introduction and Business Overview
7.4.3 Zydus Group Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Zydus Group Anthrax Treatment Product Offerings
7.4.5 Zydus Group Recent Development
7.5 Bayer AG
7.5.1 Bayer AG Company Information
7.5.2 Bayer AG Introduction and Business Overview
7.5.3 Bayer AG Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Bayer AG Anthrax Treatment Product Offerings
7.5.5 Bayer AG Recent Development
7.6 Pfizer Inc.
7.6.1 Pfizer Inc. Company Information
7.6.2 Pfizer Inc. Introduction and Business Overview
7.6.3 Pfizer Inc. Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Pfizer Inc. Anthrax Treatment Product Offerings
7.6.5 Pfizer Inc. Recent Development
7.7 EMERGENT
7.7.1 EMERGENT Company Information
7.7.2 EMERGENT Introduction and Business Overview
7.7.3 EMERGENT Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.7.4 EMERGENT Anthrax Treatment Product Offerings
7.7.5 EMERGENT Recent Development
7.8 Sanofi
7.8.1 Sanofi Company Information
7.8.2 Sanofi Introduction and Business Overview
7.8.3 Sanofi Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Sanofi Anthrax Treatment Product Offerings
7.8.5 Sanofi Recent Development
7.9 Elusys Therapeutics
7.9.1 Elusys Therapeutics Company Information
7.9.2 Elusys Therapeutics Introduction and Business Overview
7.9.3 Elusys Therapeutics Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Elusys Therapeutics Anthrax Treatment Product Offerings
7.9.5 Elusys Therapeutics Recent Development
7.10 Porton Biopharma
7.10.1 Porton Biopharma Company Information
7.10.2 Porton Biopharma Introduction and Business Overview
7.10.3 Porton Biopharma Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Porton Biopharma Anthrax Treatment Product Offerings
7.10.5 Porton Biopharma Recent Development
7.11 Lupin
7.11.1 Lupin Company Information
7.11.2 Lupin Introduction and Business Overview
7.11.3 Lupin Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Lupin Anthrax Treatment Product Offerings
7.11.5 Lupin Recent Development
7.12 Soligenix
7.12.1 Soligenix Company Information
7.12.2 Soligenix Introduction and Business Overview
7.12.3 Soligenix Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Soligenix Anthrax Treatment Product Offerings
7.12.5 Soligenix Recent Development
7.13 Takeda Pharmaceutical Company Limited
7.13.1 Takeda Pharmaceutical Company Limited Company Information
7.13.2 Takeda Pharmaceutical Company Limited Introduction and Business Overview
7.13.3 Takeda Pharmaceutical Company Limited Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Takeda Pharmaceutical Company Limited Anthrax Treatment Product Offerings
7.13.5 Takeda Pharmaceutical Company Limited Recent Development
7.14 Teva Pharmaceutical Industries Ltd.
7.14.1 Teva Pharmaceutical Industries Ltd. Company Information
7.14.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
7.14.3 Teva Pharmaceutical Industries Ltd. Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Teva Pharmaceutical Industries Ltd. Anthrax Treatment Product Offerings
7.14.5 Teva Pharmaceutical Industries Ltd. Recent Development
7.15 ARISTO Pharmaceuticals Private Limited
7.15.1 ARISTO Pharmaceuticals Private Limited Company Information
7.15.2 ARISTO Pharmaceuticals Private Limited Introduction and Business Overview
7.15.3 ARISTO Pharmaceuticals Private Limited Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.15.4 ARISTO Pharmaceuticals Private Limited Anthrax Treatment Product Offerings
7.15.5 ARISTO Pharmaceuticals Private Limited Recent Development
7.16 INDOCO REMEDIES LTD.
7.16.1 INDOCO REMEDIES LTD. Company Information
7.16.2 INDOCO REMEDIES LTD. Introduction and Business Overview
7.16.3 INDOCO REMEDIES LTD. Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.16.4 INDOCO REMEDIES LTD. Anthrax Treatment Product Offerings
7.16.5 INDOCO REMEDIES LTD. Recent Development
7.17 Paratek Pharmaceuticals, Inc.
7.17.1 Paratek Pharmaceuticals, Inc. Company Information
7.17.2 Paratek Pharmaceuticals, Inc. Introduction and Business Overview
7.17.3 Paratek Pharmaceuticals, Inc. Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Paratek Pharmaceuticals, Inc. Anthrax Treatment Product Offerings
7.17.5 Paratek Pharmaceuticals, Inc. Recent Development
7.18 DEINOVE
7.18.1 DEINOVE Company Information
7.18.2 DEINOVE Introduction and Business Overview
7.18.3 DEINOVE Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.18.4 DEINOVE Anthrax Treatment Product Offerings
7.18.5 DEINOVE Recent Development
7.19 BlueWillow Biologics.
7.19.1 BlueWillow Biologics. Company Information
7.19.2 BlueWillow Biologics. Introduction and Business Overview
7.19.3 BlueWillow Biologics. Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.19.4 BlueWillow Biologics. Anthrax Treatment Product Offerings
7.19.5 BlueWillow Biologics. Recent Development
7.20 GC Biopharma, corp.
7.20.1 GC Biopharma, corp. Company Information
7.20.2 GC Biopharma, corp. Introduction and Business Overview
7.20.3 GC Biopharma, corp. Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.20.4 GC Biopharma, corp. Anthrax Treatment Product Offerings
7.20.5 GC Biopharma, corp. Recent Development
7.21 Altimmune
7.21.1 Altimmune Company Information
7.21.2 Altimmune Introduction and Business Overview
7.21.3 Altimmune Anthrax Treatment Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Altimmune Anthrax Treatment Product Offerings
7.21.5 Altimmune Recent Development
8 Industry Chain Analysis
8.1 Anthrax Treatment Industrial Chain
8.2 Anthrax Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Anthrax Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Anthrax Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Anthrax Treatment Market Trends
    Table 2. Anthrax Treatment Market Drivers & Opportunity
    Table 3. Anthrax Treatment Market Challenges
    Table 4. Anthrax Treatment Market Restraints
    Table 5. Global Anthrax Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Anthrax Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Global Anthrax Treatment Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Anthrax Treatment Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Anthrax Treatment Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Anthrax Treatment Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Anthrax Treatment Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Anthrax Treatment
    Table 13. Global Anthrax Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anthrax Treatment as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Anthrax Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Anthrax Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Anthrax Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Anthrax Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Anthrax Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Anthrax Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Anthrax Treatment Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Anthrax Treatment Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Anthrax Treatment Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Anthrax Treatment Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Anthrax Treatment Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Anthrax Treatment Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Anthrax Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Anthrax Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Anthrax Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Anthrax Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Anthrax Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Anthrax Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Anthrax Treatment Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Anthrax Treatment Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Anthrax Treatment Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Anthrax Treatment Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Anthrax Treatment Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Anthrax Treatment Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Anthrax Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Anthrax Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Anthrax Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Anthrax Treatment Sales Value by Region (2019-2024) & (%)
    Table 44. Global Anthrax Treatment Sales Value by Region (2025-2030) & (%)
    Table 45. Global Anthrax Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Anthrax Treatment Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Anthrax Treatment Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Anthrax Treatment Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Anthrax Treatment Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Anthrax Treatment Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Anthrax Treatment Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Anthrax Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Anthrax Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Anthrax Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Anthrax Treatment Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Anthrax Treatment Sales Volume, (2025-2030) & (K Units)
    Table 57. Alembic Pharmaceuticals Company Information
    Table 58. Alembic Pharmaceuticals Introduction and Business Overview
    Table 59. Alembic Pharmaceuticals Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Alembic Pharmaceuticals Anthrax Treatment Product Offerings
    Table 61. Alembic Pharmaceuticals Recent Development
    Table 62. Integrated Bio Therapeutics Inc. Company Information
    Table 63. Integrated Bio Therapeutics Inc. Introduction and Business Overview
    Table 64. Integrated Bio Therapeutics Inc. Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Integrated Bio Therapeutics Inc. Anthrax Treatment Product Offerings
    Table 66. Integrated Bio Therapeutics Inc. Recent Development
    Table 67. Sun Pharmaceutical Industries Ltd. Company Information
    Table 68. Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
    Table 69. Sun Pharmaceutical Industries Ltd. Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Sun Pharmaceutical Industries Ltd. Anthrax Treatment Product Offerings
    Table 71. Sun Pharmaceutical Industries Ltd. Recent Development
    Table 72. Zydus Group Company Information
    Table 73. Zydus Group Introduction and Business Overview
    Table 74. Zydus Group Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Zydus Group Anthrax Treatment Product Offerings
    Table 76. Zydus Group Recent Development
    Table 77. Bayer AG Company Information
    Table 78. Bayer AG Introduction and Business Overview
    Table 79. Bayer AG Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Bayer AG Anthrax Treatment Product Offerings
    Table 81. Bayer AG Recent Development
    Table 82. Pfizer Inc. Company Information
    Table 83. Pfizer Inc. Introduction and Business Overview
    Table 84. Pfizer Inc. Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Pfizer Inc. Anthrax Treatment Product Offerings
    Table 86. Pfizer Inc. Recent Development
    Table 87. EMERGENT Company Information
    Table 88. EMERGENT Introduction and Business Overview
    Table 89. EMERGENT Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. EMERGENT Anthrax Treatment Product Offerings
    Table 91. EMERGENT Recent Development
    Table 92. Sanofi Company Information
    Table 93. Sanofi Introduction and Business Overview
    Table 94. Sanofi Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Sanofi Anthrax Treatment Product Offerings
    Table 96. Sanofi Recent Development
    Table 97. Elusys Therapeutics Company Information
    Table 98. Elusys Therapeutics Introduction and Business Overview
    Table 99. Elusys Therapeutics Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Elusys Therapeutics Anthrax Treatment Product Offerings
    Table 101. Elusys Therapeutics Recent Development
    Table 102. Porton Biopharma Company Information
    Table 103. Porton Biopharma Introduction and Business Overview
    Table 104. Porton Biopharma Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Porton Biopharma Anthrax Treatment Product Offerings
    Table 106. Porton Biopharma Recent Development
    Table 107. Lupin Company Information
    Table 108. Lupin Introduction and Business Overview
    Table 109. Lupin Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Lupin Anthrax Treatment Product Offerings
    Table 111. Lupin Recent Development
    Table 112. Soligenix Company Information
    Table 113. Soligenix Introduction and Business Overview
    Table 114. Soligenix Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Soligenix Anthrax Treatment Product Offerings
    Table 116. Soligenix Recent Development
    Table 117. Takeda Pharmaceutical Company Limited Company Information
    Table 118. Takeda Pharmaceutical Company Limited Introduction and Business Overview
    Table 119. Takeda Pharmaceutical Company Limited Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Takeda Pharmaceutical Company Limited Anthrax Treatment Product Offerings
    Table 121. Takeda Pharmaceutical Company Limited Recent Development
    Table 122. Teva Pharmaceutical Industries Ltd. Company Information
    Table 123. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
    Table 124. Teva Pharmaceutical Industries Ltd. Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Teva Pharmaceutical Industries Ltd. Anthrax Treatment Product Offerings
    Table 126. Teva Pharmaceutical Industries Ltd. Recent Development
    Table 127. ARISTO Pharmaceuticals Private Limited Company Information
    Table 128. ARISTO Pharmaceuticals Private Limited Introduction and Business Overview
    Table 129. ARISTO Pharmaceuticals Private Limited Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. ARISTO Pharmaceuticals Private Limited Anthrax Treatment Product Offerings
    Table 131. ARISTO Pharmaceuticals Private Limited Recent Development
    Table 132. INDOCO REMEDIES LTD. Company Information
    Table 133. INDOCO REMEDIES LTD. Introduction and Business Overview
    Table 134. INDOCO REMEDIES LTD. Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. INDOCO REMEDIES LTD. Anthrax Treatment Product Offerings
    Table 136. INDOCO REMEDIES LTD. Recent Development
    Table 137. Paratek Pharmaceuticals, Inc. Company Information
    Table 138. Paratek Pharmaceuticals, Inc. Introduction and Business Overview
    Table 139. Paratek Pharmaceuticals, Inc. Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Paratek Pharmaceuticals, Inc. Anthrax Treatment Product Offerings
    Table 141. Paratek Pharmaceuticals, Inc. Recent Development
    Table 142. DEINOVE Company Information
    Table 143. DEINOVE Introduction and Business Overview
    Table 144. DEINOVE Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. DEINOVE Anthrax Treatment Product Offerings
    Table 146. DEINOVE Recent Development
    Table 147. BlueWillow Biologics. Company Information
    Table 148. BlueWillow Biologics. Introduction and Business Overview
    Table 149. BlueWillow Biologics. Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. BlueWillow Biologics. Anthrax Treatment Product Offerings
    Table 151. BlueWillow Biologics. Recent Development
    Table 152. GC Biopharma, corp. Company Information
    Table 153. GC Biopharma, corp. Introduction and Business Overview
    Table 154. GC Biopharma, corp. Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 155. GC Biopharma, corp. Anthrax Treatment Product Offerings
    Table 156. GC Biopharma, corp. Recent Development
    Table 157. Altimmune Company Information
    Table 158. Altimmune Introduction and Business Overview
    Table 159. Altimmune Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 160. Altimmune Anthrax Treatment Product Offerings
    Table 161. Altimmune Recent Development
    Table 162. Key Raw Materials Lists
    Table 163. Raw Materials Key Suppliers Lists
    Table 164. Anthrax Treatment Downstream Customers
    Table 165. Anthrax Treatment Distributors List
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anthrax Treatment Product Picture
    Figure 2. Global Anthrax Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Anthrax Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Anthrax Treatment Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Anthrax Treatment Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Anthrax Treatment Report Years Considered
    Figure 7. Global Anthrax Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Anthrax Treatment Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anthrax Treatment Revenue in 2023
    Figure 10. Anthrax Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Fluoroquinolone Picture
    Figure 12. Tetracycline Picture
    Figure 13. Others Picture
    Figure 14. Global Anthrax Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Anthrax Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Anthrax Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Anthrax Treatment Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Anthrax Treatment Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Hospitals Pharmacies
    Figure 20. Product Picture of Retail Pharmacies
    Figure 21. Product Picture of Online Pharmacies
    Figure 22. Global Anthrax Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Anthrax Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Anthrax Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Anthrax Treatment Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Anthrax Treatment Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Anthrax Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Anthrax Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Anthrax Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Anthrax Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Anthrax Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Anthrax Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Anthrax Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Anthrax Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Anthrax Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Anthrax Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Anthrax Treatment Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Anthrax Treatment Sales Volume (%), (2019-2030)
    Figure 39. United States Anthrax Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Anthrax Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Anthrax Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Anthrax Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Anthrax Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Anthrax Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Anthrax Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Anthrax Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Anthrax Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Anthrax Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Anthrax Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Anthrax Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Anthrax Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Anthrax Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Anthrax Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Anthrax Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Anthrax Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Anthrax Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Anthrax Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Anthrax Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Anthrax Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 60. Anthrax Treatment Industrial Chain
    Figure 61. Anthrax Treatment Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Brigatinib Tablet Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-13E9982
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Durezol Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-22W864
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Rats Model Services Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-39V834
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Argininemia Drugs Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-11E9950
Fri Dec 27 00:00:00 UTC 2024

Add to Cart